New AstraZeneca doctor site highlights regulatory differences US/Europe #astrazeneca #health20fr

AstraZeneca's new site http://www.vimovotouchpoints.com for doctors, brings together functionalities that are obvious, practical, and yet not previously provided on pharma sites. Why?

1) download discount cards for patients:  exists

2) order samples : exists

3) watch 200 videos about medications : ? not as many

4) chat with pharma account specialists : ? not sure, don't think so

These functionalities provided useful activities to physicians. So, the site should be popular, if docs are well-informed about it.

This kind of site is however a regulatory nightmare for Europe. A live, recorded chat with pharma reps -- even if they're called account specialists, too risky

...ordering samples: no

...getting 200 videos that talk about a drug through regulatory approval...nigh onto impossible

and of course no discount cards for patients in Europe.

So, we can see through this example, that getting beyond regulatory is an allaround challenge, not just a challenge for consumer related contact, in Europe.